Foa A, Vaduganathan M, Claggett BL, Diaz R, et al. Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial. Eur J Heart Fail 2026 Feb 12:xuag023. doi: 10.1093.
PMID: 41771140